Hopital Tenon

The medical center is at the forefront of oncology research, focusing on innovative treatments for various types of cancer. The center's work in non-small cell lung cancer (NSCLC) is particularly noteworthy, with trials exploring the efficacy of pembrolizumab and lorlatinib in advanced stages. Additionally, the center is pioneering studies in breast cancer, investigating the impact of trastuzumab and pertuzumab in HER2-positive cases.

• Non-Small Cell Lung Cancer (NSCLC)
• Breast Cancer
• Prostate Cancer

Through these studies, the center contributes significantly to the development of targeted therapies and personalized medicine approaches, enhancing treatment outcomes and patient quality of life.

In the realm of immunology, the center is advancing the understanding and treatment of autoimmune and inflammatory diseases. Research on ANCA vasculitis and eosinophilic granulomatosis with polyangiitis is leading to new insights into disease mechanisms and potential therapeutic interventions.

• ANCA Vasculitis
• Eosinophilic Granulomatosis with Polyangiitis
• Chronic Inducible Urticaria

The center's work in this field is crucial for developing novel treatments that can modulate the immune system more effectively, offering hope for patients with chronic and debilitating conditions.

The center is a leader in nephrology research, particularly in the study of IgA nephropathy and lupus nephritis. Trials involving sibeprenlimab and ravulizumab are exploring new avenues for managing these complex kidney diseases.

• IgA Nephropathy
• Lupus Nephritis
• End-Stage Renal Disease

By focusing on these areas, the center is contributing to the development of therapies that aim to preserve kidney function and improve patient outcomes in chronic kidney diseases.

Research in infectious diseases at the center is making significant strides, particularly in the treatment of HIV and co-infections. Studies on broadly neutralizing antibodies and novel antiretroviral therapies are paving the way for improved management of HIV.

• HIV
• HIV-HBV Co-infection
• Familial Mediterranean Fever

The center's efforts in this domain are vital for advancing therapeutic strategies that enhance viral suppression and improve the quality of life for individuals living with chronic infections.

In respiratory medicine, the center is conducting groundbreaking research on conditions such as idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease (COPD). Trials are evaluating the efficacy of novel therapeutic approaches to manage and treat these challenging respiratory conditions.

• Idiopathic Pulmonary Fibrosis
• Chronic Obstructive Pulmonary Disease (COPD)
• Non-Small Cell Lung Cancer (NSCLC)

Through these initiatives, the center is contributing to the development of therapies that aim to improve lung function and patient quality of life in chronic respiratory diseases.